Does NATALIZUMAB Cause Sars-cov-2 test positive? 127 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 127 reports of Sars-cov-2 test positive have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.2% of all adverse event reports for NATALIZUMAB.
127
Reports of Sars-cov-2 test positive with NATALIZUMAB
0.2%
of all NATALIZUMAB reports
1
Deaths
26
Hospitalizations
How Dangerous Is Sars-cov-2 test positive From NATALIZUMAB?
Of the 127 reports, 1 (0.8%) resulted in death, 26 (20.5%) required hospitalization, and 3 (2.4%) were considered life-threatening.
Is Sars-cov-2 test positive Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 127 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Sars-cov-2 test positive?
OCRELIZUMAB (1,421)
ADALIMUMAB (1,301)
DUPILUMAB (860)
NIRMATRELVIR\RITONAVIR (538)
LENALIDOMIDE (469)
SECUKINUMAB (378)
CERTOLIZUMAB PEGOL (361)
RISANKIZUMAB-RZAA (335)
RITUXIMAB (305)
UPADACITINIB (281)
Which NATALIZUMAB Alternatives Have Lower Sars-cov-2 test positive Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK